Quadrature Capital’s Novartis NVS Stock Holding History

Quadrature Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.7M	Buy	240,579 +126,290	+111%	+$18.9M	0.32%	65
2026 Q1	$17.5M	Buy	114,289 +69,220	+154%	+$10.6M	0.21%	109
2025 Q4	$6.21M	Buy	+45,069	New	+$5.9M	0.06%	192
2016 Q4	–	Sell	-42,962	Closed	-$3.04M	–	741
2016 Q3	$3.04M	Buy	+42,962	New	+$3.13M	0.26%	95
2016 Q2	–	Sell	-177,961	Closed	-$11.6M	–	615
2016 Q1	$11.6M	Buy	+177,961	New	+$12.1M	1.6%	10
2015 Q3	–	Sell	-12,946	Closed	-$1.14M	–	307
2015 Q2	$1.14M	Buy	+12,946	New	+$1.19M	1.03%	32

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Quadrature Capital's NVS Position: Q2 2026 in Review

Quadrature Capital increased its Novartis (NVS) stake by 111% in Q2 2026, buying an estimated $18.9M and bringing the position to 240,579 shares worth $37.7M. The position accounts for 0.32% of the portfolio, ranked #65.

Quadrature Capital first reported a position in NVS in Q2 2015 and has held it in 6 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Quadrature Capital held 240,579 shares of Novartis worth $37.7M as of Q2 2026.
Quadrature Capital bought 126,290 Novartis shares in Q2 2026, an estimated $18.9M.
Novartis made up 0.32% of Quadrature Capital's portfolio in Q2 2026, its #65 holding.
Quadrature Capital first reported a position in Novartis in Q2 2015 and has held it in 6 quarters since.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.